Nausea and vomiting Vertigo Motion sickness Labyrinthine disorders

50 mg up to 3 times daily

Molecular weight :266.4

%Protein binding :No data

%Excreted unchanged in urine : <1

Volume of distribution (L/kg) :No data

half-life – normal/ESRD (hrs) :20/–

20 to 50 : Dose as in normal renal function

10 to 20 : Dose as in normal renal function

<10 : Dose as in normal renal function

CAPD :Unknown dialysability. Dose as in normal renal function

HD :Unknown dialysability. Dose as in normal renal function

HDF/high flux :Unknown dialysability. Dose as in normal renal function

CAV/VVHD :Unknown dialysability. Dose as in normal renal function

Potentially hazardous interactions with other drugsNone known

–

IV, IM, oral

Slow IV

Increased cerebral sensitivity in patients with renal failure